Wellington, NZ, 8th December 2016: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, has today released its investor newsletter for December 2016.
The newsletter contains information on the company’s recent achievements and commercial activity including:
- Launch of VolparaEnterprise 2.0 and papers presented at the Radiological Society of North America (RSNA);
- Update on rollout of VolparaEnterpriseTM, first sales and pipeline;
- Publication of clinical data and peer-reviewed articles highlighting the utility of
Volpara’s tools to improve breast cancer detection;
- Volpara’s collaboration with Microsoft;
- Volpara’s inclusion in the Tyrer-Cuzick breast cancer risk model;
- Launch of the breast density awareness campaign in Australia.
To view Newsletter please download PDF attached:
Download this document
